Effect of sample dilution on serum free light chain concentration by immunonephelometric assay

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1798-1804

  Vercammen, Martine ^a   Meirlaen, Patricia ^a   Broodtaerts, Linda ^a   Broek, Isabelle Vande ^b   Bossuyt, Xavier ^c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b AZ Nikolaas   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antigen excess; Free light chain; Immunonephelometric assay; Monoclonal antibodies

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DILUTION; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNONEPHELOMETRIC ASSAY; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; NEPHELOMETRY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN LIGHT CHAINS; NEPHELOMETRY AND TURBIDIMETRY;

EID: 79960619104     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.06.021     Document Type: Article

References (19)

1. Dispenzieri A., Kyle R., Merlini G., et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009, 23:215-224.
2. Vermeersch P., Vercammen M., Holvoet A., Vande Broek I., Delforge M., Bossuyt X. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Clin Chim Acta 2009, 410:54-58.
3. Abraham R., Charlesworth M., Owen B., et al. Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma. Clin Chem 2002, 48:1805-1811.
4. Tate J., Devinder G., Cobcroft R., Hickman P. Practical considerations for the measurement of free light chains in serum. Clin Chem 2003, 49:1252-1257.
5. Lopez J., Dauwalder O., Joly P., Dimet I., Bienvenu J., Bemon H. Intérêt et limites des dosages sériques et urinaires des chaînes légères libres pour le diagnostic et le suivi des dysglobulinémies monoclonales. Ann Biol Clin 2006, 64:287-297.
6. Tate J., Mollee P., Dimeski G., Carter A., Devinder G. Analytical performance of serum free light chain assay during monitoring of patients with monoclonal free light chain diseases. Clin Chim Acta 2007, 376:30-36.
7. Tate J., Bazeley S., Sykes S., Mollee P. Quantitative serum free light chain assay - analytical issues. Clin Biochem Rev 2009, 30:131-140.
8. de Kat Angelino C.M., Raymakers R., Teunesen M.A., Jacobs J.F., Klasen I.S. Overestimation of serum kappa free light chain concentration by immunonephelometry. Clin Chem 2010, 56:1188-1190.
9. Briand P., Decaux O., Caillon H., Grosbois B., Le Treut A., Guenet L. Analytical performance of the serum free light chain assay. Clin Chem Lab Med 2010, 48:73-79.
10. Davern S., Tang L., Williams T., et al. Immunodiagnostitic capabilities of anti-free immunoglobulin light chain monoclonal antibodies. Am J Clin Pathol 2008, 130:702-711.
11. Levinson S. Regarding the overestimation of sserum kappa free light chain. Clin Chem 2011, 57:775-777.
12. Bosmann M., Kößler J., Stolz H., Walter U., Knop S., Steigerwald U. Detection of serum free light chains: the problem with antigen excess. Clin Chem Lab Med 2010, 48:1419-1422.
13. Murata K., Clark R.J., Lockington K.S., Tostrud L.J., Greipp P.R., Katzmann J.A. Sharply increased serum free light-chain concentration after treatment for multiple myeloma. Clin Chem 2010, 56:16-18.
14. Levinson S. Hook effect with lambda free light chain in serum free light chain assay. Clin Chim Acta 2010, 411:1834-1836.
15. Krouwer J.S., Cembrowski G.S., Tholen D.W. EP10-A3. Preliminary evaluation of quantitative clinical laboratory measurement procedures. CLSI 2006, 26(34).
16. Pepperkok B., Zeuch A., Jehlicka-Rose R., Bartel J. Incidence and handling of antigen excess when measuring free light chains. Hematol Rep 2010, 2(s2):A2.
17. Dispenzieri A., Zhang L., Katzmmann J., et al. Appraisal of immunoglobulin free light chain as a marker of response. Blood 2008, 111:4908-4915.
18. Gertz M., Commenzo R., Falk R., et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 2005, 79:319-328.
19. Solanski M., Matters D. Evaluation of parameters for measuring free immunoglobulin light-chains with automated antigen excess detection on the Siemens BNII analyser. Hematol Rep 2010, 2(s2):A4.